TPP traditional vs advanced

Traditional TPPs are focused on regulatory acceptance and core label defining claims. However, this  is not sufficient for future success. An approval alone does not guarantee reimbursement and commercial success. The innovative or advanced TPP needs to extend beyond traditional parameters and should include elements such as evidence strategy, digital/diagnostic integration, market access equity, sustainability and even lifecycle management. 

Whilst in startup biotech organizations resources are focused on pre-clinical and early clinical development additional competencies are needed. This is where consultancy support is needed, if these competencies are not available in-house. 

The value of an innovative or advanced TPP is not only to guide internal strategy and execution, it also becomes a tool for fundraising and partnering discussions.